- Home
- FUSB vs ECOR Comparison
FUSB vs ECOR Comparison
Compare FUSB & ECOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FUSB | ECOR |
|---|---|---|
| Founded | 1952 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 90.1M | 81.0M |
| IPO Year | 1995 | 2018 |
Fundamental Metrics
Financial Performance| Metric | FUSB | ECOR |
|---|---|---|
| Price | $16.35 | $7.46 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $18.00 |
| AVG Volume (30 Days) | 5.3K | ★ 142.6K |
| Earning Date | 04-29-2026 | 05-06-2026 |
| Dividend Yield | ★ 1.72% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.33 | N/A |
| Revenue | N/A | ★ $32,032,000.00 |
| Revenue This Year | N/A | $33.60 |
| Revenue Next Year | N/A | $30.40 |
| P/E Ratio | $49.55 | ★ N/A |
| Revenue Growth | N/A | ★ 27.20 |
| 52 Week Low | $10.47 | $4.16 |
| 52 Week High | $16.50 | $10.50 |
Technical Indicators
Market Signals| Indicator | FUSB | ECOR |
|---|---|---|
| Relative Strength Index (RSI) | 60.91 | 43.32 |
| Support Level | $15.75 | $4.75 |
| Resistance Level | N/A | $8.26 |
| Average True Range (ATR) | 0.19 | 0.93 |
| MACD | 0.02 | -0.33 |
| Stochastic Oscillator | 100.00 | 18.86 |
Price Performance
Historical ComparisonAbout FUSB First US Bancshares Inc.
First US Bancshares Inc is a bank holding company. The Bank conducts general commercial banking business and offers banking services such as demand, savings, individual retirement accounts, and time deposits, personal and commercial loans, safe deposit box services, and remote deposit capture. The Bank provides a range of commercial banking services to small and medium-sized businesses, property managers, business executives, professionals, and other individuals.
About ECOR electroCore Inc.
electroCore Inc is a bioelectronic technology company whose mission is to improve health and quality of life through non-invasive bioelectronic technologies. Its two commercial products are gammaCore non-invasive vagus nerve stimulation, or nVNS, and Quell Fibromyalgia, or Quell. It also sells Truvaga and TAC-STIM products, which are handheld, personal-use consumer products developed to promote general wellness and human performance. It operates in one segment: Bioelectronic Innovations. Geographically, it operates in the United States, the United Kingdom, Japan, and Other.